Fertility's Hidden Hurdle: Early Steps Matter Most

Infertility is a widespread issue, affecting approximately one in six adults globally. In India, a substantial number of individuals facing infertility do not even reach the initial treatment stages. The success of fertility journeys often hinges on factors addressed long before the visible IVF cycle, such as timely diagnosis and treatment of issues like blocked fallopian tubes or assessing ovarian reserve through simple blood tests.

The often-underestimated initial phase of investigation involves multiple blood tests, scans, and specialist visits. This investigative period alone can accumulate costs running into tens of thousands of rupees, a significant financial and time burden for working women. Many abandon their fertility treatment plans during this crucial investigative stage, which has the most profound long-term impact.

Geographical disparities further complicate access, with specialized fertility clinics concentrated in major cities. This leaves individuals in smaller towns with limited or no options, transforming essential appointments into arduous and costly journeys. While India has strengthened clinic regulations since 2022 with the ART Act, the focus is now shifting towards improving actual access to care.

Financial accessibility remains a major hurdle, as most insurance policies do not cover fertility treatments. Even when coverage exists, it is often through limited corporate plans. Integrated public health services or primary care inclusion, as seen in countries like Morocco and Indonesia, could offer a more equitable pathway for early fertility assessments, addressing the problem before expensive treatment cycles begin.